Display options
Share it on

Iran J Pharm Res. 2014;13:35-42.

Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents.

Iranian journal of pharmaceutical research : IJPR

Masoud Faghih Akhlaghi, Salimeh Amidi, Marjan Esfahanizadeh, Marjan Daeihamed, Farzad Kobarfard

Affiliations

  1. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran, Vali Asr Ave, Niayesh Junction, Tehran, Iran.
  2. Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Iran.
  3. Department of Pharmaceutics, School of Paharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  4. Department of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran, Vali Asr Ave, Niayesh Junction, Tehran, Iran. ; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Iran.

PMID: 24711827 PMCID: PMC3977051

Abstract

A number of N-arylmethyl substituted indole derivatives have been synthesized and their effectiveness against ADP and arachidonic acid induced platelet aggregation in human plasma was determined. The desired compounds were synthesized by reacting the appropriate aniline derivative with isatin (or substituted isatin) to form the corresponding imine structures. The so formed compound was then activated using sodium hydride and reacted with the proper substituted benzyl halides. Among the tested compounds, derivatives 4a, 4c, 4d, 4f-i and 4k were the most potent compounds with satisfactory IC50 values (under 38.5 μM) for inhibition of platelet aggregation induced by arachidonic acid. All indole derivatives without substitution on position 1 of the indole ring, exhibited either weaker activities or were not active at all.

Keywords: 1-(substituted benzyl)-3-(phenylimino)indolin-2-one; Antiplatelet; N-arylmethyl indole; Platelet aggregation

References

  1. Hematology Am Soc Hematol Educ Program. 2011;2011:62-9 - PubMed
  2. Arch Pharm (Weinheim). 2006 Mar;339(3):115-22 - PubMed
  3. J Biol Chem. 2009 Jun 12;284(24):16108-16117 - PubMed
  4. Bioorg Med Chem. 2008 Feb 1;16(3):1262-78 - PubMed
  5. Circ J. 2010 Apr;74(4):597-607 - PubMed
  6. Ther Adv Cardiovasc Dis. 2010 Aug;4(4):249-75 - PubMed
  7. Nature. 1962 Jun 9;194:927-9 - PubMed
  8. Iran J Pharm Res. 2013 Winter;12(Suppl):91-103 - PubMed
  9. Circulation. 2010 Feb 2;121(4):586-613 - PubMed
  10. Blood Rev. 2009 Mar;23(2):61-5 - PubMed
  11. Int J Biochem Cell Biol. 2010 Nov;42(11):1762-6 - PubMed
  12. Eur J Med Chem. 2012 Aug;54:823-33 - PubMed
  13. Curr Drug Targets. 2013 Jan 1;14(1):3-12 - PubMed
  14. Drugs. 2010 May 7;70(7):887-908 - PubMed
  15. J Cardiovasc Pharmacol. 2013 Feb;61(2):166-74 - PubMed
  16. Nutr Metab Cardiovasc Dis. 2013 Sep;23(9):799-807 - PubMed
  17. J Biol Chem. 2006 Nov 24;281(47):35914-21 - PubMed

Publication Types